Adsence code

This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

Amebo gist

By  March 29, 2020   No comments

Coronavirus: Germany’s Finance Minister commits suicide over Covid -19 worries

Published
2 hours ago on
By
The Finance Minister, Hesse state Germany, Thomas Schaefer, has committed suicide.
State Premier, Volker Bouffier, made the announcement on Sunday.
He disclosed that Schaefer had become “deeply worried” over how to cope with the economic crisis coronavirus had caused.
“We are in shock, we are in disbelief and above all we are immensely sad,” Bouffier said in a recorded statement.
Schaefer, 54, was found dead near a railway track on Saturday.
The Wiesbaden prosecution’s office said they believe he died by suicide.
The State Hesse is the home of Germany’s financial hub, Frankfurt.
In three months, coronavirus has killed over 30,000 people in 200 countries.
In one month, Nigeria has recorded nearly 100 COVID-19 cases and two deaths, including one American.

Related Topics:

facebook sharing button Share
whatsapp sharing button Share
twitter sharing button Tweet
email sharing button Email
print sharing button


Read More

Buhari Bans all Movement in Lagos, Abuja for 2 weeks over Coronavirus

By  March 29, 2020   No comments

Read More

BREAKING NEWS

By  March 29, 2020   No comments
President Muhammadu Buhari has placed a two-week curfew in Lagos and the Federal Capital Territory, Abuja.
The president made this known via a National Live Broadcast today. He revealed that this was in line with safety measures to prevent the spread of the deadly virus.
“Based on the advice of the Federal Ministry of Health and the NCDC, I am directing the cessation of all movements in Lagos and the FCT for an initial period of 14 days with effect from 11 pm on Monday, 30th March 2020. This restriction will also apply to Ogun State due to its close proximity to Lagos and the high traffic between the two States.”
“All citizens in these areas are to stay in their homes. Travel to or from other states should be postponed. All businesses and offices within these locations should be fully closed during this period.”
“The Governors of Lagos and Ogun States, as well as the Minister of the FCT, have been notified. Furthermore, heads of security and intelligence agencies have also been briefed.”
“We will use this containment period to identify, trace and isolate all individuals that have come into contact with confirmed cases. We will ensure the treatment of confirmed cases while restricting further spread to other States.”
Read More

MORE RESEACH NEED TO BE DONE

By  March 29, 2020   No comments

More research needs to be done

It is too early to declare Avigan as an effective treatment for COVID-19 -- more clinical tests will need to be conducted. And the drug, which is owned by Fujifilm Holdings (OTC:FUJIY), has the potential to cause serious birth defects if taken by pregnant women, so it must be used only under proper medical supervision.
Many other pharmaceutical and biotech companies are looking to develop treatments for the potentially deadly disease, or find them in their existing catalogs. Gilead Sciences (NASDAQ:GILD) has taken what appears to be an early lead in that quest. On Feb. 26, the biotech company initiated two phase 3 clinical trials in several Asian countries to investigate the efficacy of its antiviral drug, remdesivir, as a treatment for COVID-19. Those trials will enroll a total of 1,000 COVID-19 patients, 600 of whom have moderate manifestations of the disease, and 400 of whom are experiencing more severe cases. Patients in the studies will be given oral doses of remdesivir for five or 10 days.

Read More

POSSIBLE DRUGS USE TO TREAT COVID-19 PATIENT AT THE MILD STAGE

By  March 29, 2020   1 comment
Worldwide, there are now more than 222,000 confirmed cases of COVID-19, and the novel coronavirus has caused more than 9,000 deaths, according to the Johns Hopkins University Coronavirus Resource Center. But there is some good news coming out of China. Researchers have found that Avigan, a drug developed in Japan for the flu, appears to significantly speed up recovery from COVID-19.
According to a Chinese researcher, the drug was used in clinical trials in the regions of Wuhan and Shenzhen. Patients who took the drug turned negative for the SARS-CoV-2 virus that causes the disease in a median of four days after they had become positive -- much faster than patients not taking the drug, who turned negative for the virus in a median of 11 days. Also, 91% of the patients who received the medicine saw their lung functions improve, compared to just 62% of those who didn't take the drug.
Woman wearing face mask
Read More

COVID-19 CURE NEWS

By  March 29, 2020   No comments


There’s worrying news around the world of people self-medicating at home with the drugs chloroquine and hydroxychloroquine to treat COVID-19. There’s since been reports of chloroquine poisoning and even death after taking the drug. Scientists first reported chloroquine’s potential against coronaviruses after the Sars epidemic in 2003.
Part of the recent confusion seems to have followed US president Donald Trump’s announcement on Twitter that implied hydroxychloroquine and another drug (the antibiotic azithromycin) taken together could treat novel coronavirus. The US Food and Drug Administration released a statement in response, saying they’re still looking into whether chloroquine can treat people with mild to moderate symptoms of COVID-19. Neither of these drugs have been approved in the US to treat COVID-19. Tests are still being conducted elsewhere, including in China, to see whether they can help treat patients admitted to hospital with COVID-19.
Chloroquine has been around for more than 80 years. It was developed as an antimalarial drug but is now also used to treat conditions including rheumatoid arthritis and systemic and discoid lupus erythematosus (lupus). It was produced to provide another treatment option to quinine, an older antimalarial drug, which came from the bark of cinchona trees.
Hydroxychloroquine, which has been around since 1955, is similar to chloroquine but less toxic. But it does have some side effects, including stomach problems and long-term problems for the eyes. Like chloroquine, hydroxychloroquine is used to treat rheumatoid arthritis and lupus, and is also used for managing sun allergies.
Chloroquine has been used to treat malaria for many years, but it stopped working against malaria caused by the Plasmodium Falciparum parasite which is common in sub-Saharan Africa. Despite this, chloroquine is still available to buy in Nigeria where people have starting taking it for COVID-19 – leading to reports of accidental poisonings.
The seriousness of the problem has led the Nigeria Centre for Disease Control to announce on Twitter that chloroquine is not approved for COVID-19 and that self-medicating with the drug will cause harm – and could lead to death.
Chloroquine is not yet proven to work against COVID-19, though news reports originating in China have speculated otherwise. Scientists have asked Chinese researchers to share details of their findings.
Read More